Literature DB >> 10919935

Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis.

N Stettler1, D A Kawchak, L L Boyle, K J Propert, T F Scanlin, V A Stallings, B S Zemel.   

Abstract

BACKGROUND: Several cross-sectional studies have shown improvement in the growth of children with cystic fibrosis (CF) because of increased awareness of and more comprehensive care of their special nutritional needs. However, longitudinal data on the nutritional status of these children are rare.
OBJECTIVE: The objective was to compare changes in growth, body composition, and nutritional status between children with and without CF.
DESIGN: This was a prospective 3-y cohort study of 25 children aged 5-10 y with CF, mild pulmonary disease, and pancreatic insufficiency and of 26 healthy control children. Three methods were used to assess body composition: measurements of skinfold thickness, total body water by deuterium oxide, and total-body electrical conductivity. Growth and body-composition changes over time were analyzed by a longitudinal mixed-effects model.
RESULTS: Over the 3 y of the study, the statural growth of the boys with CF was slower than that of the control subjects (P = 0.004). The same divergence over time between the boys with and without CF was observed for fat-free mass assessed by skinfold-thickness measurements and total body water (P = 0.008 and 0.02, respectively) and for fat mass assessed by skinfold-thickness measurements and total-body electrical conductivity (P = 0.009 and 0.001, respectively). The differences in the pattern of changes in growth and body composition were less striking for girls.
CONCLUSIONS: Despite comprehensive care, the growth of boys with CF was impaired on the basis of height, fat-free mass, and fat mass, when observed longitudinally. Caution should be used when interpreting cross-sectional measurements because they often do not detect suboptimal growth.

Entities:  

Mesh:

Year:  2000        PMID: 10919935     DOI: 10.1093/ajcn/72.2.407

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Young adults with cystic fibrosis are shorter than healthy peers because their parents are also short.

Authors:  Teresa Arrigo; Filippo De Luca; Concetta Sferlazzas; Cristina Lucanto; Maria Francesca Messina; Mariella Valenzise; Lucia Marseglia; Malgorzata Wasniewska
Journal:  Eur J Pediatr       Date:  2005-08-16       Impact factor: 3.183

2.  Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis.

Authors:  Kelly A Dougherty; Joan I Schall; Virginia A Stallings
Journal:  Am J Clin Nutr       Date:  2010-06-16       Impact factor: 7.045

3.  Altered de novo lipogenesis contributes to low adipose stores in cystic fibrosis mice.

Authors:  Ilya Bederman; Aura Perez; Leigh Henderson; Joshua A Freedman; James Poleman; Dana Guentert; Nicholas Ruhrkraut; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-07       Impact factor: 4.052

4.  Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.

Authors:  G Steinkamp; B Wiedemann
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

5.  Measurement of percentage of body fat in 411 children and adolescents: a comparison of dual-energy X-ray absorptiometry with a four-compartment model.

Authors:  Aviva B Sopher; John C Thornton; Jack Wang; Richard N Pierson; Steven B Heymsfield; Mary Horlick
Journal:  Pediatrics       Date:  2004-05       Impact factor: 7.124

Review 6.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Alexandra L Haagensen; Ben Carter; Zbys Fedorowicz; Brian W Houston
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 7.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

8.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Ben Carter; Melissa Putman
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.